MedPath

Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding

Not Applicable
Conditions
Abnormal Uterine Bleeding
Interventions
Device: Transvaginal sonography
Registration Number
NCT01786798
Lead Sponsor
Chulalongkorn University
Brief Summary

The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
560
Inclusion Criteria
  • Premenopausal women aged over than 35
  • Abnormal uterine bleeding (menorrhagia/menometrorrhagia/metrorrhagia)
  • Accept transvaginal examination (pelvic examination and ultrasound)
  • Informed consent
Exclusion Criteria
  • Severe uterine bleeding resulting in unstable vital signs
  • Pregnancy
  • Current medications: anticoagulants, selective serotonin reuptake inhibitor (SSRI), antipsychotics, corticosteroids, hormones, herbs
  • Intrauterine device
  • Genital tract pathologies: infection, submucous myoma distorting uterine cavity
  • Systemic diseases that may cause coagulopathies: Thyroid disease, liver disease, pituitary/ hypothalamus diseases
  • Not able to retrieve endometrial tissue

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transvaginal sonographyTransvaginal sonography-
Primary Outcome Measures
NameTimeMethod
The accuracy of endometrial thickness and endometrial pattern detected by transvaginal ultrasound in predicting endometrial hyperplasia and endometrial cancer.14 months

The endometrial thickness will be measured in millimeter, at the mid-sagittal plane of the uterus, near the uterine fundus. The measurement will be performed 3 times, from basal layer of the anterior to basal layer of the posterior wall of uterine cavity. The average value of 3 measurements will be used for statistical analysis.

The endometrial patterns are categorized into 3 groups:

1. Triple-layer appearance

2. Mixed echogenic pattern

3. Hyper-echogenic pattern

Secondary Outcome Measures
NameTimeMethod
To identify the cut-off points of endometrial thickness that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer.14 months

The results of endometrial thickness will be compared with the endometrial pathologies.The cut-off points of endometrial thickness, in millimeter, that can differentiate normal endometrial pathology and endometrial hyperplasia/endometrial cancer will be analyzed using receiver operating characteristic (ROC) curve.

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath